Common man's 'sweet' doctor of Mysore

Dr V Lakshminarayan being felicitated at a programme organised by Mysore Clinical Society on the occasion of the release of his book on diabetes and its effects at a programme, in Mysore.  dh photo

Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD). The sedentary lifestyle and food habits are increasing the risk factors for the younger population to become prone to diabetes, even as more youngsters are found positive for high level of blood sugar.

One name that is synonymous with diabetes in Mysore is Dr V Lakshminarayan’s. For more than three decades,  Dr Lakshminarayan is treating patients with diabetes and at the same time doing his study on the patterns of diabetes, its effects and finding ways to improve the health of diabetics. A majority of his study has been published in reputed journals in India and abroad.

Lakshminarayan was presented Vaidya Rathna award in recognition of his service in the medical field.

His study on Efficacy of Safety of Valsartan in Preventing the Progression of Nephropathy in Indian diabetes miletus patients received wider acceptance, including from American Diabetes Association.

Talking to City Herald, Dr Lakshminarayan said Microalbuminuria (MAU), the condition where the albumin exceeds 30 mg in urine requires attention. It is the earliest clinical sign of diabetes nephropathy. Many studies suggest that MAU is an independent risk factor for both cardiovascular disease, CKD and ESRD.

Over a period of 10-15 years, the improper treatment of diabetes is bound to affect kidney, which can lead to the end-stage renal disease. “Once a patient reaches ESRD,  medicine will not be of much use. The patient has to either undergo dialysis twice a week or have to go for the transplantation of kidney.

Therefore, early treatment is necessary to prevent ESRD detecting MAU in early stage by Micro Albuminuria test,” says Dr Lakshminarayan.  The 68th scientific session of American Diabetes Association held at Moscone Convention Center, San Francisco, Los Angeles, United States in 2009 declared that the study was beneficial in preventing progression of diabetes nephropathy at the stage of micro albuminuria in DMT patients.

The ADA journal also published Lakshminarayan’s study which  said that no adverse effects were found in any patients treated with Valsartan for 16 weeks.   Dr Lakshminarayan has also made elaborate study on relationship between diabetes and sexual dysfunction and other subjects. 

He was the personal physician for Rashtrakavi Kuvempu for about a decade. Though, Kuvempu was not a diabetic, Dr Lakshminarayan treated him for hypertension and other general old-age related health disorders. “The service that I rendered for Kuvempu will be an unforgettable memory in my life,” the physician says.

Dr Lakshminarayan who currently runs Shreehari Diabetes Foundation on Anikethana Road in Kuvempunagar has served in various capacities in State government and in medical education field. He is widely regarded as common man’s doctor due to his selfless service in medical field. Lakshminarayan, who is a lifetime member of American Diabetes Association is invited as the honorary delegate for the annual ADA conference to be held at United States next week.

DH Newsletter Privacy Policy Get top news in your inbox daily
Comments (+)